4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-006734
Options or other derivatives
- Chief Commercial Officer acquired 45,212 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McMullin David Chief Commercial Officer | 2019-03-05 | Grant or award · Employee Stock Option (Right to Buy) | +45,212 | 45,212 | D | ||
Loading xslF345X03/doc4.xml…